These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Transcatheter Aortic Valve Implantation with the Portico Valve: 2-Year Outcomes of a Multicenter, Real-World Registry. Didagelos M; Ninios V; Kakderis C; Lakkas L; Kouparanis A; Nikas D; Naka KK; Rammos A; Zegkos T; Kamperidis V; Ninios I; Evangelou S; Tsalikakis DG; Michalis L; Ziakas A Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629642 [TBL] [Abstract][Full Text] [Related]
48. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up. Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402 [TBL] [Abstract][Full Text] [Related]
49. Long-term Outcomes in Octogenarians Following Isolated Aortic Valve Replacement. Simões Costa S; Rijo D; Monteiro JP; Martins D; Santos Paulo N; Vouga L; Guerra M Rev Port Cir Cardiotorac Vasc; 2017; 24(3-4):133. PubMed ID: 29701365 [TBL] [Abstract][Full Text] [Related]
50. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up. Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081 [TBL] [Abstract][Full Text] [Related]
51. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients. Schäfer U; Deuschl F; Schofer N; Frerker C; Schmidt T; Kuck KH; Kreidel F; Schirmer J; Mizote I; Reichenspurner H; Blankenberg S; Treede H; Conradi L Int J Cardiol; 2017 Apr; 232():247-254. PubMed ID: 28118931 [TBL] [Abstract][Full Text] [Related]
52. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol. Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410 [TBL] [Abstract][Full Text] [Related]
53. [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]. Zahn R; Schiele R; Kilkowski C; Klein B; Schwarz AK; Zeymer U; Lehmann A; Cornelius B; Horack M; Saggau W; Werling C Dtsch Med Wochenschr; 2010 Aug; 135(33):1589-95. PubMed ID: 20717862 [TBL] [Abstract][Full Text] [Related]
54. Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk. Acconcia MC; Perrone MA; Sergi D; Di Luozzo M; Marchei M; De Vico P; Sili Scavalli A; Pannarale G; Chiocchi M; Gaudio C; Romeo F; Caretta Q; Barillà F Cardiol J; 2023; 30(4):595-605. PubMed ID: 34622437 [TBL] [Abstract][Full Text] [Related]
55. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry. Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653 [TBL] [Abstract][Full Text] [Related]
56. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the "gray zone" between transcatheter aortic valve implantation and conventional surgery: a propensity-matched, multicenter analysis. D'Onofrio A; Messina A; Lorusso R; Alfieri OR; Fusari M; Rubino P; Rinaldi M; Di Bartolomeo R; Glauber M; Troise G; Gerosa G J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1010-6. PubMed ID: 22974713 [TBL] [Abstract][Full Text] [Related]
57. [Indications and outcomes of TAVI (transcatheter aortic valve implantation) in Iceland]. Larusdottir KJ; Gudmundsson H; Johnsen A; Sigurdsson MI; Gudbjartsson T; Gudmundsdottir IJ Laeknabladid; 2021 Mar; 107(3):123-129. PubMed ID: 33625378 [TBL] [Abstract][Full Text] [Related]
58. Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes. Corcione N; Berni A; Ferraro P; Morello A; Cimmino M; Albanese M; Nestola L; Bardi L; Pepe M; Giordano S; Biondi-Zoccai G; Rigattieri S; Giovannelli F; Giordano A Catheter Cardiovasc Interv; 2022 Jul; 100(1):114-119. PubMed ID: 35557027 [TBL] [Abstract][Full Text] [Related]
59. Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results. Fraccaro C; Campante Teles R; Tchétché D; Saia F; Bedogni F; Montorfano M; Fiorina C; Meucci F; De Benedictis M; Leonzi O; Barbierato M; Dumonteil N; Stolcova M; Maffeo D; Compagnone M; Brito J; Chieffo A; Tarantini G Catheter Cardiovasc Interv; 2020 Nov; 96(5):1128-1135. PubMed ID: 32627924 [TBL] [Abstract][Full Text] [Related]
60. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. Urena M; Webb JG; Cheema A; Serra V; Toggweiler S; Barbanti M; Cheung A; Ye J; Dumont E; DeLarochellière R; Doyle D; Al Lawati HA; Peterson M; Chisholm R; Igual A; Ribeiro HB; Nombela-Franco L; Philippon F; Garcia Del Blanco B; Rodés-Cabau J JACC Cardiovasc Interv; 2014 Feb; 7(2):128-136. PubMed ID: 24440024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]